(Q48495381)

12 February 2018

title

Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial (English)

1 reference

12 February 2018

0 references

1 reference

3

1 reference

12 February 2018

author name string

C F McDonald

series ordinal

1

1 reference

12 February 2018

R M D Zebaze

series ordinal

2

1 reference

12 February 2018

language of work or name

English

0 references

publication date

11 July 2006

1 reference

12 February 2018

Osteoporosis International

published in

1 reference

12 February 2018

volume

17

1 reference

12 February 2018

issue

10

1 reference

12 February 2018

page(s)

1546-1551

1 reference

12 February 2018

Calcitriol treatment is not effective in postmenopausal osteoporosis

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-006-0158-2

Inhaled corticosteroids and hip fracture: a population-based case-control study.

21 January 2018

1 reference

12 December 2020

Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study

1 reference

12 December 2020

1 reference

12 December 2020

Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review

1 reference

12 December 2020

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

12 December 2020

Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease

1 reference

12 December 2020

High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group

1 reference

12 December 2020

Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium

1 reference

12 December 2020

Calcitriol in the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women

1 reference

12 December 2020

Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function

1 reference

12 December 2020

Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids

1 reference

12 December 2020

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases

1 reference

12 December 2020

Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation

1 reference

12 December 2020

Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study

1 reference

12 December 2020

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

1 reference

12 December 2020

Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients : a 4-year longitudinal study

1 reference

12 December 2020

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis with calcitriol or calcium

1 reference

12 December 2020

Influence of 1 alpha-(OH)D3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment; a double blind controlled study

1 reference

12 December 2020

Effect of rocaltrol on bone mass in patients with pulmonary disease treated with corticosteroids.

1 reference

12 December 2020

Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study.

1 reference

12 December 2020

Steroid-induced fractures and bone loss in patients with asthma

1 reference

12 December 2020

The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency

1 reference

12 December 2020

Bone mineral density in perimenopausal women with asthma: a population-based cross-sectional study

1 reference

12 December 2020

Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis

1 reference

12 December 2020

Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol.

1 reference

12 December 2020

A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group

1 reference

12 December 2020

Inhaled and Nasal Corticosteroid Use and the Risk of Fracture

1 reference

12 December 2020

Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids

1 reference

12 December 2020

Long-term influence of inhaled corticosteroids on bone metabolism and density. Are biological markers predictors of bone loss?

1 reference

12 December 2020

The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study

1 reference

12 December 2020

Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids

1 reference

12 December 2020

Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism

1 reference

12 December 2020

One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density

1 reference

12 December 2020

Effects of inhaled glucocorticoids on bone density in premenopausal women

1 reference

12 December 2020

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis

1 reference

12 December 2020

10.1007/S00198-006-0158-2

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018